2016
DOI: 10.1039/c5ra25477a
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and in vitro evaluation of donepezil-based reactivators and analogues for nerve agent-inhibited human acetylcholinesterase

Abstract: Donepezil-based reactivators 1–3 show a better ability (8 fold higher) than pralidoxime to reactivate VX-hAChE, and oxime 2 is 5 to 11 fold more efficient than pralidoxime and HI-6 respectively to reactivate of VX-hBChE.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
22
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 32 publications
(23 citation statements)
references
References 32 publications
1
22
0
Order By: Relevance
“…With such a low barrier, it appears that AChE reactivation by oximes is solely dependent on the protonation state in the active site rather than nucleophilicity of the oxime. Obviously, binding of the oxime is also important, but this has been largely addressed by experimental and docking studies …”
Section: Discussionmentioning
confidence: 99%
“…With such a low barrier, it appears that AChE reactivation by oximes is solely dependent on the protonation state in the active site rather than nucleophilicity of the oxime. Obviously, binding of the oxime is also important, but this has been largely addressed by experimental and docking studies …”
Section: Discussionmentioning
confidence: 99%
“…Also, the late stage Sonogashira cross‐coupling of alkyne 1v with 2 , provided the expected 6‐alkynyl‐3‐fluoro‐2‐pyridinaldoxime 3v in excellent yield (87 %), which is an analog of a recently published hybrid reactivator of OP‐inhibited AChE. [14b]…”
Section: Resultsmentioning
confidence: 99%
“…Novelo xime structures based on the Alzheimer's disease drug donepezilbyR enard and co-workers. [109] Chem. Eur.J.…”
Section: Developing Non-permanently Charged Oxime Reactivators Of Op-mentioning
confidence: 99%
“…Renard and co-workers synthesized and tested uncharged oxime reactivators making use of the anti-Alzheimer's disease drug donepezil as ap eripheral site ligand. [109] The benzyl moiety of donepezil wasr eplaced with a3 -hydroxypyridinaldoxime as the nucleophilic portion of the molecule (Figure 23). In total, four variants (28-31)w ere synthesized ande valuated for their reactivation ability versus VX-, sarin-, paraoxon-, and tabun-inhibited hAChE.…”
Section: Developing Non-permanently Charged Oxime Reactivators Of Op-mentioning
confidence: 99%